These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 18591576

  • 1. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.
    Nelson JC, Delucchi K, Schneider LS.
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):558-67. PubMed ID: 18591576
    [Abstract] [Full Text] [Related]

  • 2. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.
    Nelson JC, Baumann P, Delucchi K, Joffe R, Katona C.
    J Affect Disord; 2014 Oct; 168():269-75. PubMed ID: 25069082
    [Abstract] [Full Text] [Related]

  • 3. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty.
    Mallery L, MacLeod T, Allen M, McLean-Veysey P, Rodney-Cail N, Bezanson E, Steeves B, LeBlanc C, Moorhouse P.
    BMC Geriatr; 2019 Nov 12; 19(1):306. PubMed ID: 31718566
    [Abstract] [Full Text] [Related]

  • 4. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.
    JAMA; 2007 Apr 18; 297(15):1683-96. PubMed ID: 17440145
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.
    J Clin Psychiatry; 2011 Dec 18; 72(12):1660-8. PubMed ID: 22244025
    [Abstract] [Full Text] [Related]

  • 6. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials.
    Nelson JC, Papakostas GI.
    Am J Psychiatry; 2009 Sep 18; 166(9):980-91. PubMed ID: 19687129
    [Abstract] [Full Text] [Related]

  • 7. Treatment of depression--newer pharmacotherapies.
    Mulrow CD, Williams JW, Trivedi M, Chiquette E, Aguilar C, Cornell JE, Badgett R, Noël PH, Lawrence V, Lee S, Luther M, Ramirez G, Richardson WS, Stamm K.
    Psychopharmacol Bull; 1998 Sep 18; 34(4):409-795. PubMed ID: 10513454
    [Abstract] [Full Text] [Related]

  • 8. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
    Nelson JC, Delucchi K, Schneider LS.
    Int J Geriatr Psychiatry; 2009 May 18; 24(5):539-44. PubMed ID: 19334041
    [Abstract] [Full Text] [Related]

  • 9. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.
    Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN.
    Ann Intern Med; 2011 Dec 06; 155(11):772-85. PubMed ID: 22147715
    [Abstract] [Full Text] [Related]

  • 10. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P.
    Encephale; 2012 Feb 06; 38(1):86-96. PubMed ID: 22381728
    [Abstract] [Full Text] [Related]

  • 11. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, Reis C, Normann C, Anghelescu IG, Correll CU.
    CNS Spectr; 2016 Oct 06; 21(5):403-418. PubMed ID: 27686028
    [Abstract] [Full Text] [Related]

  • 12. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.
    Berlim MT, Van den Eynde F, Daskalakis ZJ.
    J Clin Psychiatry; 2013 Feb 06; 74(2):e122-9. PubMed ID: 23473357
    [Abstract] [Full Text] [Related]

  • 13. Moderators of outcome in late-life depression: a patient-level meta-analysis.
    Nelson JC, Delucchi KL, Schneider LS.
    Am J Psychiatry; 2013 Jun 06; 170(6):651-9. PubMed ID: 23598969
    [Abstract] [Full Text] [Related]

  • 14. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
    Iovieno N, Papakostas GI.
    J Clin Psychiatry; 2012 May 06; 73(5):676-83. PubMed ID: 22569112
    [Abstract] [Full Text] [Related]

  • 15. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.
    Amick HR, Gartlehner G, Gaynes BN, Forneris C, Asher GN, Morgan LC, Coker-Schwimmer E, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.
    BMJ; 2015 Dec 08; 351():h6019. PubMed ID: 26645251
    [Abstract] [Full Text] [Related]

  • 16.
    O'Connor EA, Whitlock EP, Gaynes B, Beil TL.
    ; 2009 12 08. PubMed ID: 20722174
    [Abstract] [Full Text] [Related]

  • 17. A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia.
    Nelson JC, Devanand DP.
    J Am Geriatr Soc; 2011 Apr 08; 59(4):577-85. PubMed ID: 21453380
    [Abstract] [Full Text] [Related]

  • 18. Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.
    Furukawa TA, Cipriani A, Atkinson LZ, Leucht S, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A, Salanti G.
    Lancet Psychiatry; 2016 Nov 08; 3(11):1059-1066. PubMed ID: 27726982
    [Abstract] [Full Text] [Related]

  • 19. Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians.
    Gartlehner G, Gaynes BN, Amick HR, Asher GN, Morgan LC, Coker-Schwimmer E, Forneris C, Boland E, Lux LJ, Gaylord S, Bann C, Pierl CB, Lohr KN.
    Ann Intern Med; 2016 Mar 01; 164(5):331-41. PubMed ID: 26857743
    [Abstract] [Full Text] [Related]

  • 20. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH, Robbins-Welty GA, Smagula SF, Karp JF, Butters MA, Lenze EJ, Mulsant BH, Blumberger D, Anderson SJ, Dew MA, Lotrich F, Aizenstein HJ, Diniz BS, Reynolds CF.
    JAMA Psychiatry; 2016 Apr 01; 73(4):329-36. PubMed ID: 26963689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.